Celecoxib Japan Observational Study for the Patients With Acute Pain

• Status: Completed
• Trial end date: 2013-04-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is to assess the safety and efficacy of celecoxib on the pain relief from acute pain.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Astellas Pharma Inc
• Treatments: Celecoxib

Criteria

Inclusion Criteria:

• Patients with traumatic pain, post-surgical pain and tooth extract pain

Exclusion Criteria:

• Hyperreactive to sulfonamide

• Aspirin asthma patients

• Peptidic ulcer patients

• Serious liver disease patients

• Serious kidney disease patients

• Serious heart failure patients

• End of pregnancy